Survey of genital lichen sclerosus in women and men

Archives of Gynecology and Obstetrics

Volumn 266, Issue 2, 2002, Pages 86-91

  Hagedorn, M ^a   Buxmeyer, B ^a   Schmitt, Y ^a   Bauknecht, T ^a  

^a Department of Dermatology Darmstadt ^*

Author keywords

Androgens; Antithyroid antibodies; Borrelia antibodies; Lichen sclerosus; Therapy

Indexed keywords

ANDROSTANOLONE; ANTIFUNGAL AGENT; CORTICOSTEROID; ESTROGEN; LEVOTHYROXINE; ORAL CONTRACEPTIVE AGENT; POTASSIUM IODIDE; PRASTERONE; PRASTERONE SULFATE; PRILOCAINE; TESTOSTERONE; THYMUS EXTRACT; TRIAMCINOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DISEASE COURSE; FEMALE; HEALTH SURVEY; HIRSUTISM; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRURITUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CHILD; DIHYDROTESTOSTERONE; FEMALE; FEMALE UROGENITAL DISEASES; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; GERMANY; HEALTH SURVEYS; HORMONES; HUMANS; INFECTION; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; PAIN; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 0036911072     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040100209     Document Type: Article

References (28)

1. Aberer E, Stanek G (1987) Histological evidence of spirochetal origin of morphea and lichen sclerosus et atrophicus. Am J Dermatol 9:374-379
2. Aberer E, Kollegger H, Kristoferitsch W, Stanek G (1988) Neuroborreliosis in morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol 19:820-825
3. Bornstein J, Heifetz S, Kellner Y, Stolar Z, Abramovici H (1988) Clobetasol dipropionate 0,05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. AM J Obstet Gynecol 178:80-84
4. Carli P, Cattaneo A, Pimpinelli N, Cozza A, Bracco G, Gianotti B (1991) Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus at atrophicus. Dermatologica 182:18-22
5. Dillon WI, Ghassan Ms, Fivenson DP (1995) Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atropicus of patients from North America. J Am Acad Dermatol 33:617-620
6. Edwards L (1994) Vulvovaginal disease. Curr Probl Dermatol 6:185-220
7. Erbach-Fürstenau I (1991) Zur Klinik und Therapie der Vulvadystrophien. Med Dissertation, Universität Freiburg
8. Farrell AM, Marren P, Dean D, Wojnarowska F (1999) Lichen sclerosus: evidence that immunological changes occur at all levels of the skin. Br J Dermatol 140:1087-1092
9. Feldmann R, Harms M (1991) Lichen sclerosus et atrophicus. Hautarzt 42:147-153
10. Friedrich EG, Kalra PS (1984) Lichen sclerosus et atrophicus. N Engl J Med 310:488-491
11. Garzon MC, Paller AS (1999) Ultrapoint topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol 135:525-528
12. Godeau G, Frances C, Hornbeck W, Brechemier D, Robert L (1982) Isolation and partial characterization of an elastase-type protease in human vulva fibroblasts: its possible involvement in vulvar elastic tissue destruction of patients with lichen sclerosus et atrophicus. J Invest Dermatol 78:270-275
13. Grimmer H (1974) Gut- und bösartige Erkrankungen der Vulva, Klinik und Histologie. Groß, Berlin
14. Hagedorn M (1990) Vulvar dystrophies and lichen sclerosus the view of the dermatologist. In. Gross G, Jablonska S, Pfister H, Stegner HE (eds) Genital papillomavirus infections. Springer Berlin Heidelberg New York, pp 153-156
15. Hagedorn M, Thomas C (1987) Vulvadystrophien. Zentralbl Haut 154:8
16. Harrington CI, Gelsthorpe K (1981) The association between lichen sclerosus et atrophicus and HLA-B40. Br J Dermatol 104:561-562
17. Kiene P, Milde-Langosch K, Löning T (1991) Human papillomavirus infection in vulvar lesions of lichen sclerosus et atropicus. Arch Dermatol Res 283:445-448
18. Meffert JJ, Davis BM, Grimwood RE (1995) Lichen sclerosus. J Am Acad Dermatol 32:393-416
19. Meyrick Thomas RH, Ridley CM, Black MM (1983) The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br J Dermatol 109:661-664
20. Meyrick Thomas RH, Ridley CM, Black MM (1984) The association of lichen sclerosus et atrophicus and autoimmune disease in males - an addendum. Br J Dermatol 111:371
21. Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM (1988) Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women. Br J Dermatol 118:41-46
22. Paslin D (1996) Androgens in the topical treatment of lichen sclerosus. Int J Dermatol 35:298-301
23. Purcell KG, Spencer LV, Simpson PM, Helman SW, Oldfather JW, Fowler JF (1990) HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol 126:1043-1045
24. Ridley CM (1992) Lichen sclerosus. Dermatol Clin 10:309-323
25. Ross SA, Sanchez JL, Taboas JO (1990) Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol 12:357-362
26. Schemp C, Bocklage H, Lange R, Kolmel HW, Orfanos CE, Gollnick H (1993) Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 100:717-720
27. Shelley WB, Shelley ED, Grunenwald MA, Andres TJ, Ramnuth A (1999) Long-term antibiotic therapy for balanitis xerotica obliterans. J Am Acad Dermatol 40:69-72
28. Von Krogh GEO (1999) Genital lichen sclerosus et atrophicus (LSA) - Management and therapy. J Eur Acad Dermatol Venerol [Suppl. 2] 12:58